Impact of intrauterine growth restriction on preterm lung disease

Arun Sasi1, Vinita Abraham1, Miranda Davies-Tuck2

  • 1Monash Newborn, Monash Children's Hospital, Melbourne, Vic., Australia.

Insights

Intrauterine growth restriction (IUGR) significantly increases the risk of chronic lung disease (CLD) and death in preterm infants. IUGR infants require more respiratory support and home oxygen at discharge.

Area of Science:

  • Neonatal Medicine
  • Respiratory Medicine
  • Pediatric Pulmonology

Background:

  • Intrauterine growth restriction (IUGR) is a significant contributor to prematurity and associated morbidities.
  • Infants born with IUGR and small for gestational age (SGA) status face increased risks.
  • Understanding the pulmonary impact of IUGR in extremely preterm infants is crucial.

Purpose of the Study:

  • To evaluate the impact of IUGR on short-term respiratory outcomes in preterm infants (<32 weeks).
  • To compare respiratory morbidity in infants with IUGR (birthweight <10th centile) versus appropriate for gestational age (AGA) controls.
  • To analyze outcomes based on gestational age subgroups (<28 and ≥28 to <32 weeks).

Main Methods:

  • Retrospective study design.
  • Inclusion of 153 IUGR infants and 306 non-IUGR (AGA) controls.
  • Primary outcomes: chronic lung disease (CLD), CLD or death, and need for home oxygen at discharge.

Main Results:

  • IUGR infants exhibited significantly higher rates of CLD (45% vs. 17%), death (16% vs. 4.6%), and CLD or death (46% vs. 21.5%) compared to AGA controls.
  • Higher rates of home oxygen dependency (13.7% vs. 6.5%) and prolonged respiratory support were observed in the IUGR group.
  • IUGR was identified as the strongest predictor for CLD (aOR 8.4) and CLD or death (aOR 12.7) across all gestations.

Conclusions:

  • Intrauterine growth restriction is a major risk factor for adverse short-term pulmonary outcomes in preterm infants.
  • IUGR is associated with increased rates of CLD, combined CLD or death, and oxygen dependency at discharge.
  • These findings underscore the importance of monitoring and managing respiratory health in preterm infants with IUGR.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
66.6K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.9K